Tourmaline Bio Inc Sustainability Reports

Tourmaline Bio, Inc. is a clinical-stage biotechnology company developing transformative medicines for patients with life-altering immune and inflammatory diseases.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

FIGI: BBG00NX995T1

No reports are currently available in our catalogue.